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Background: Treatment for children with attention deficit/hyperactivity disorder (ADHD)
today is predominantly pharmacological. While it is the most common treatment, it might
not always be the most appropriate one. Moreover, long term effects remain unclear.
Behavior therapy (BT) and non-pharmacological treatments such as neurofeedback (NF) are
promising alternatives, though there are no routine outpatient care/effectiveness studies
yet that have included children with medication or changes in medication.
Methods/design: This paper presents the protocol of a randomized controlled trial to
compare the effectiveness of a Slow Cortical Potential (SCP) NF protocol with self-
management (SM) in a high frequent outpatient care setting. Both groups (NF/SM)
receive a total of 30 high frequent therapy sessions. Additionally, 6 sessions are reserved
for comorbid problems. The primary outcome measure is the reduction of ADHD core
symptoms according to parent and teacher ratings.
Preliminary Results: Untill now 58 children were included in the study (48 males), with a
mean age of 8.42 (1.34) years, and a mean IQ of 110 (13.37). Conners-3 parent and teacher
ratings were used to estimate core symptom change. Since the study is still ongoing, and
children are in different study stages, pre-post and follow-up results are not yet available for
all children included. Preliminary results suggest overall good pre-post effects, though. For
parent and teacher ratings an ANOVA with repeated measures yielded overall satisfying
pre-post effects ( 2η 0.175–0.513). Differences between groups (NF vs. SM) could not yet
be established (p = 0.81).
Discussion: This is the first randomized controlled trial to test the effectiveness of a NF
protocol in a high frequent outpatient care setting that does not exclude children on or with
changes in medication. First preliminary results show positive effects. The rationale for the
trial, the design, and the strengths and limitations of the study are discussed.
Trial registration: This trial is registered in www.clinicaltrials.gov as NCT01879644.
Keywords: ADHD, neurofeedback, self-management, slow cortical potential training, behavior therapy,
effectiveness
BACKGROUND
For children with Attention Deficit/Hyperactivity Disorder
(ADHD) the European guidelines recommend a multimodal
treatment (Graham et al., 2011), as well as the new German
guidelines that recommend a treatment with medication only if
other treatments are not effective.1 While this is recommended,
this seems not be the reality in clinical practice. The treatment for
children with ADHD today is predominantly pharmacological,
1http://www.awmf.org/leitlinien/detail/ll/028-019.html
with increasing prescription rates for psycho-stimulants (Bar-
baresi et al., 2002; Dalsgaard et al., 2013; Steinhausen and Bis-
gaard, 2014). it is the most common treatment and with respect
to short terms the most effective one for the majority of children
with ADHD (Van der Oord et al., 2008), it might not always be
the most appropriate one, due to possible non-response, side-
effects, or parental preferences (Lofthouse et al., 2012). Moreover,
long term effects remain unclear. About one third of the children
treated with stimulants does not respond (Du Paul et al., 1998;
Monastra et al., 2005; Lofthouse et al., 2012), adverse medication
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side effects such as insomnia, and decreased appetite are often
reported (U.S. Department of Health and Human Services, 1999;
Schachter et al., 2001; Graham et al., 2011), and improvement
often seems not to be maintained after treatment discontinuation
(Swanson et al., 2001; Abikoff et al., 2004a,b; Molina et al., 2009).
Of the children treated with psycho-stimulants, 44–75% do not
satisfactorily profit from this treatment in long-term follow-up
(MTA Cooperative Group, 1999; Swanson et al., 2001; Molina
et al., 2009; Nieweg, 2010), and protective long-term effects, i.e.,
on substance abuse (Molina et al., 2009, 2013), or on academic
achievement, social and interpersonal skills could not consistently
be established (Whalen and Henker, 1991; Greenhill et al., 1999;
Molina et al., 2009; van de Loo-Neus et al., 2011; Mrug et al.,
2012). Accordingly, some families are hesitant about medication
treatment (Visser and Lesesne, 2003; Berger et al., 2008), and
treatment alternatives are warranted.
Behavior therapy (BT) and non-pharmacological treatments
such as neurofeedback (NF) are promising and supposedly side
effect free alternatives (Molina et al., 2009; Moriyama et al., 2012).
Evidence suggests positive short-term effects for different NF
protocols (Arns et al., 2009; Lofthouse et al., 2012), and there is
also some, though sparse evidence for long-term effects (Arns
et al., 2009; Lofthouse et al., 2012). While the efficacy as well
as the need for these approaches are still discussed controversely
(Jensen et al., 2007; Swanson et al., 2008; Fabiano et al., 2009),
recent quantitative reviews and meta-analyses have shed light
on the efficacy of non-pharmacological treatments for ADHD
(Van der Oord et al., 2008; Arns et al., 2009; Fabiano et al.,
2009; Lofthouse et al., 2012; Moriyama et al., 2012; Sonuga-
Barke et al., 2013; Hodgson et al., 2014). Overall, those reviews
and meta-analyses report robust medium to large effect sizes for
non-pharmacological interventions on ADHD (Fabiano et al.,
2009; Hodgson et al., 2014) as well as for NF protocols (Arns
et al., 2009, 2014; Lofthouse et al., 2012; Moriyama et al.,
2012; Hodgson et al., 2014; Liew, 2014). The meta-analysis by
Sonuga-Barke et al. (2013) differentiates findings for NF and
behavioral interventions, demonstrating larger and significant
effects by raters closest to the therapeutic setting, but dimin-
ishing and non-significant effects for both interventions when
probably blinded assessment (i.e., teacher ratings) was employed.
Since blinded assessment was overall rare in the studies included,
and reduced the already small numbers of studies subjected to
meta-analysis further (from k = 8 NF studies to k = 4 with
probably blinded assessment; and from k = 9 behavioral inter-
vention studies to k = 5 with probably blinded assessment), those
results should be interpreted with respect to this. More studies
with higher quality and more objective outcome measures are
thus warranted, though subjective improvements of parents and
children are not unimportant, since an association between a
positive parent-child interaction and a better outcome has been
observed previously (Schachar et al., 1987; Taylor et al., 1991,
1996; Tully et al., 2004; Drabick et al., 2006; Christiansen et al.,
2010).
As Lofthouse et al. (2012, p. 366) admit, blinding in psy-
chotherapy studies is harder compared to medication studies,
since knowledge of the treatment is required for a therapist
and makes a placebo condition virtually impossible (see also
Zuberer et al. in this Frontiers Research Topic). Nevertheless, two
pilot-studies report on EEG NF double-blind randomized placebo
controlled trials. Both demonstrated feasibility, but no differ-
ences between the active and placebo condition, yet (Lansbergen
et al., 2011; Arnold et al., 2012). The eight existing studies using
triple blinding in NF protocols are also inconclusive. Four of
them report significant positive effects of medium to large size
(DeBeus, 2006; Leins et al., 2006; Picard et al., 2006; DeBeus
and Kaiser, 2011), whereas the four more recent ones report
negative results (Logemann et al., 2010; Perreau-Linck et al., 2010;
Lansbergen et al., 2011; Arnold et al., 2012). Moriyama et al.
(2012, p 592), criticize, that the negative findings of those four
studies “might have been determined by the use of suboptimal
NF, because all of these studies used very experimental protocols
and in none of them, the principals of learning theory were
applied to ensure that subjects were really under conditioning
procedures”. This is a key element, though, since in NF protocols
operant conditioning procedures are applied to help participants
learn to gain self-control over EEG patterns that are associated
with attentional processes (Heinrich et al., 2007; Gevensleben
et al., 2009b). Conditioning failures will thus be related to neg-
ative outcomes, since core principals of the therapy are then in
question (for the combination of NF and behavioral therapeu-
tic aspects see also Vollebregt et al. in this Frontiers Research
Topic).
One study compared a NF slow cortical potential (SCP)
protocol with BT (Drechsler et al., 2007). In the study, NF
SCP in a single setting (20 high frequent 90 min sessions in
2 weeks with a further 5 weekly/twice weekly 90 min sessions
after a 5 week break) is compared with a group therapy (total
of 15 ninety minute sessions weekly to twice weekly) based on
behavioral interventions such as self-management (SM) and par-
ent training, demonstrating more pronounced treatment effects
for the NF SCP group. But the total number of sessions (NF
SCP: 25 vs. BT: 15), the setting (NF SCP: single vs. BT: group),
frequency (NF SCP: dayly vs. BT: weekly/twice weekly), and
duration of the two interventions are not comparable, hampering
conclusions with respect to the efficacy of the interventions. A
more recent study by Garcia et al. (see this Frontiers Research
Topic) compares 57 children with ADHD that were randomly
assigned to three different treatments: NF theta/beta training
sessions, methylphenidate treatment, and BT. Their results reveal
specific changes in EEG variables, specifically related to NF
theta/beta training; results on ADHD symptoms are not reported,
yet.
AIMS OF THE TRIAL
The aim of the present study is to establish whether a NF protocol
under outpatient care conditions is at least as effective as an
approved and established behavioral treatment (SM), as results
in the Drechsler et al. (2007) study suggest. The current study
is designed to compare a SCP NF training with a behavioral
SM training (SM: Lauth and Schlottke, 2009). To date, NF is
not yet approved as a psychotherapeutic intervention by health
care providers in Germany, and to our knowledge there is no
effectiveness study investigating the feasibility and effects of NF
under regular outpatient care conditions.
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We are thus interested in whether NF (SCP training) is a
true treatment alternative to behavioral interventions that are
approved by health care providers. Since the studies so far were
experimental ones establishing effects of NF protocols that did
not allow medication or changes in medication, this question is
not answered, yet.
The primary research question is:
1. Is a SCP NF protocol under outpatient care conditions at
least as effective as an approved and established behavioral
treatment (SM) at the end of treatment, and at six and twelve
months follow-up?
Further examination of secondary research questions
1. EEG-patterns:
Does NF result in specific changes of EEG patterns com-
pared to SM? Are there specific associations between neuroreg-
ulation skills and clinical outcomes?
2. Child outcomes:
Do both treatments (NF and SM) improve children’s exec-
utive functions, quality of life, self-concept and school grades?
And is treatment response in both treatments moderated by
children’s perceived social support?
3. Parent outcomes:
Do both treatments (NF and SM) improve parenting skills,
parental perceived social support and expressed emotion (EE)?
Does the parent group with additional social support (PE +
SU) show enhanced social support after treatment and more
positivity and warmth towards the child compared to the
group with PE only? Is this moderated by comorbidity?
METHODS
PARTICIPANTS
Inclusion criteria
The study is performed with children either newly diagnosed
with ADHD or with verified diagnoses. Participants are children
referred for ADHD treatment either by their parents, pediatri-
cians, or psychiatrists. To be eligible for the study, the children
have to meet the following inclusion criteria: aged seven to
eleven, full command of the German language, current DSM-
IV diagnosis of ADHD (either combined, predominantly inat-
tentive or predominantly hyperactive/impulsive subtype), IQ≥80
(short version of the WISC; information, picture arrangement,
similarities and block-design; Sattler, 2008, p. 186). Children
with comorbid disorders are not excluded from the study, and
behavioral treatment of comorbid conditions is included in the
treatment plan. The rational for this is based on the effectiveness
design of the study. The majority of the children with ADHD
presents with comorbid disorders (Kadesjö et al., 2003; Willcutt
et al., 2005; Gadow et al., 2006; Jakobson and Kikas, 2007; Anney
et al., 2008; Semrud-Clikeman and Bledsoe, 2011; Stein et al.,
2011; Vakil et al., 2012), and parents and children seeking help in
our outpatient clinic request treatment of all impairing problems,
and not just ADHD (please refert to the preliminary result section
for information on comorbidities). The children under stimulant
medication are also not excluded from the study, but dose and
possible changes will be recorded.
Exclusion criteria
Children with symptoms of inattention, hyperactivity or impul-
sivity due to other medical reasons such as hyperthyreosis, autism,
epilepsy, brain disorders and any genetic or medical disorder
associated with externalizing behavior.
DESIGN AND PROCEDURE
Recruitment and consent
The Psychotherapeutic Outpatient Clinic of the Department
of Psychology, Clinical Psychology, at the University of Mar-
burg treats children, adolescents and adults with psycholog-
ical disorders. Patients can refer themselves or are referred
by their pediatricians, psychiatrists, or general practitioners.
Parents and children interested in the study are sent a full
study description with separate information for parents, teach-
ers, and children, and Conners-3 questionnaires for parents
and teachers as well as questions on demographics and ther-
apy expectations. Screen positive patients are invited for a
semi-structured diagnostic interview (Kiddie-Sads-Present and
Lifetime Version; K-SADS-PL; Kaufman et al., 1996) with a
licensed child and adolescent psychotherapist to assess ADHD
and possible comorbid disorders. If ADHD is diagnosed, the
patient and his/her parents are informed about the treatment
options and receive oral information based on the written
information already sent out to the families. If the child
fulfills diagnostic criteria and the family wants to partici-
pate in the study, informed consent is signed by the parents
and their children, and further diagnostic assessments are
scheduled.
Randomization and treatment allocation
The children are randomized to receive either NF or SM train-
ing. Parents of children are randomized to parent training
groups with either psychoeducation only (PE), or PE enhanced
with additional social support (PE+SU). Treatment allocation
is performed by computer programming stratified for gender
and stimulant medication. In this way, we aim to ensure that
trial arms are balanced with respect to the baseline character-
istics gender and use of ADHD medication. Patients, parents,
therapists, and investigators were not blinded for the treat-
ment allocation. Teachers are blind with respect to treatment
allocation.
Procedure
Both the NF and SM interventions are manualized, equal in
setting (single), duration, frequency, parental involvement, and
supporting token economies (for details on this please refer
to treatment protocols of this article). The rationale for those
treatment parameters is based on the results of the available
meta-analyses (Arns et al., 2009; Esser and Blank, 2011; Zwi
et al., 2011; Lofthouse et al., 2012; Moriyama et al., 2012;
Sonuga-Barke et al., 2013; Hodgson et al., 2014). The SM
training is approved and refunded by insurance providers in
Germany for ADHD therapy (for the efficacy of SM train-
ings for ADHD see the reviews by Saile, 1996; Fabiano et al.,
2009); NF is only refunded in health care settings that also
do research in the field. Since our department is a university
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FIGURE 1 | Flow-chart of the study. R = Randomization of parents to either PE or PE+SU.
one, it is possible to get NF training refunded by in such a
setting.
Figure 1 provides an overview of the trial flow. After informed
consent and baseline assessment (T1), a diagnostic assessment
of ADHD and possible comorbid disorders with the K-SADS-
PL follows. During T1 all primary and secondary outcome
measures, neuropsychological tests, and quantitative EEGs are
scheduled. Children are off medication 48 h prior to all diag-
nostic assessments to not distort results due to treatment. The
same procedure is applied for all further assessments. After con-
firmation of ADHD diagnosis, randomization takes place. The
children in both groups then receive 24 high frequent therapy
sessions (NF or SM) over twelve weeks with up to three 1 h
sessions per week, since such an intensive training has proved
to be highly effective (Strehl et al., 2011). After the first twelve
sessions in 4 weeks, there is a 1 week break followed by the
next 4 weeks with high frequent training. After 24 sessions only
Conners-3 parent ratings are used for T2 assessment and there
is another break for 1 week. Additionally for both groups 6
individualized BT sessions are reserved for comorbid problems
after T2 assessment. Depending on the disorder and treatment
selected, those sessions might be high frequent or scheduled
only weekly. After the comorbid sessions, six high frequent NF
or SM follow that end the therapy. T3 assesses post-treatment
effects (all primary and secondary outcomes). Five months after
end of treatment, all children are offered three booster training
sessions (either NF or SM according to allocation). Six (T4)
and twelve months (T5) after treatment termination follow-
up assessments with all primary and secondary outcome mea-
sures are scheduled. Parent groups are accompanying children’s
therapy. Table 1 gives a detailed overview of the treatment
plan.
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Table 1 | Overview of all assessment and treatment sessions of the
study.
Session Content Duration
1 Outpatient assessment and informed
consent; information on study participation
100 min
Diagnostic assessment
2–4 Pre-assessments of all primary and 50 min per
secondary outcome measures (T1) session
Randomization of children and parents
5 Feedback of test results 50 min
6 Psycho-education children 50 min
Intervention
Accompanying Parent Training
7–18 Block I: 50 min per
High frequent NF/SM treatment over
4 weeks (12 sessions)
session
Break (1 week)
19–30 Block II: 50 min per
High frequent NF/SM treatment over
4 weeks (12 sessions)
session
Break (1 week) and T2 assessment*
31–36 Block III—part 1: 50 min per
Behavior therapy of comorbid problems
(6 sessions)
session
37–42 Block III—part 2: 50 min per
High frequent NF/SM treatment
(6 sessions)
session
43 Post assessment (T3) 50 min
Follow-up assessment and booster sessions
44–46 3 Booster sessions ca. 5 months after 50 min per
treatment discontinuation session
47 6-months follow-up (T4) 50 min
48 12-months follow-up (T5) 50 min
*T2 assessment: only Conners 3© parent rating scales.
TREATMENT PROTOCOLS
Neurofeedback
Before treatment all children receive standardized PE on ADHD
(Lauth and Schlottke, 2009). For NF training in this study we
use the Thera Prax® (NeuroConn©) NF system. It offers sev-
eral different feedback animations and the option to upload
pictures which keeps the training diversified and motivates
children. During training sessions, the children take seat in a
comfortable chair with a head- and armrest in front of a com-
puter screen and are introduced to the training as kind of a
computer game that helps them learn to modulate their brain
activity.
We use the feedback protocol of SCP training that has been
incorporated in many NF studies (Strehl et al., 2006; Heinrich
et al., 2007; Gevensleben et al., 2009a,b, 2010; Arns et al., 2014).
The children’s task is to generate negative and positive SCPs
by getting into an attentive (negativity trials) or a relaxed state
(positivity trials). The aim of the training is to steer a moving
object (i.e., an airplane, a fish, a spaceship) that appears on
the screen in front of them in the requested direction (arrow
upwards indicates negativity trial; arrow downwards indicates
positivity trial). The children can choose a training object at
the beginning of each therapy session. In the transfer trials, the
children do not see the object, but only the direction of the
arrow. The children are instructed to sit as still as possible during
the training, to avoid laughing and talking, but to concentrate
on the screen in front of her/him. No specific instruction is
given to the children on how to succeed in negativity or pos-
itivity trials, but just to be attentive to feedback and to find
the most effective mental strategy to steer the object into the
requested direction. As there is no unique strategy for NF training,
the children are given examples that have been successful for
some children (i.e., negativity trials: “Think of something you
find exciting like sitting in a race car or standing on a diving
board”; positivity trials: “Those strategies are used in situations
requiring relaxation. Think of something you find calming and
pacifying like listening to soothing music”). After a successful
trial a sun appears on the screen (reinforcement). Additionally,
a token plan is used that enables the children to earn up to 5
tokens per session if they stay attentive during the whole session.
A full token plan of 15 tokens (every third session) can be
exchanged into small rewards by parents that are agreed upon at
the beginning of the training together with the parents and the
child.
Participants in the NF condition receive a total of 30 sessions
of SCP training. Each therapy session consists of three runs.
One run consists of 40 trials (8 min) resulting in a total of
24 min NF training per session (see Figure 2 for details). A
trial lasts for 8 s (2 s baseline period, 6 s feedback period).
Inter-trial interval is set to 5 ± 1 s. Between each of the three
runs there is a short break of several minutes which can be
used by the therapist to motivate and praise the child and to
talk about problems and use of strategies (i.e., “What was your
strategy for negativity/positivity trials?”, “How did it work?”,
“What else could you try as a negativity/positivity trial strat-
egy?”). The last 10 min of each session are reserved for joint
play which is an important aspect of motivating the child and
strengthening the therapeutic relationship. Feedback is calculated
from the vertex (Cz) and is referenced against both mastoids
(bandwidth 0.01–30 Hz, sampling rate: 256 Hz), and vertical
as well as horizontal eye movements are corrected online with
electrodes placed above and below the left eye, and electrodes on
the right and left side of the face (4 electrooculography channels,
EGO; for details of the protocol see Strehl, 2009). Ocular artifact
removal is possible with DC-EEG as described in Schlegelmilch
et al. (2004). The ratio of negativity to positivity is set to 1:1,
and negativity/positivity trials are presented in random order.
All sessions start with no threshold, but if the child has a hit
rate (correct responses) of ≥70%, thresholds are introduced
automatically. Those start with an initial 5% threshold, and
are followed in steps of 5% if the child continuous to score
≥70%.
The first two runs in every therapy session include no
transfer trials, i.e., the child gets continuous visual feedback,
whereas the third run is set to 100% transfer (for this ratio-
nale see also Vollebregt et al. in this Frontiers Research Topic).
Although no continuous feedback is given on transfer trials,
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FIGURE 2 | Neurofeedback Protocol with three therapy blocks and a total of 30 sessions.
a sun appears at the end of the trials to provide informa-
tion about success (reinforcement). Transfer trials are thought
to support generalization to everyday life situations (Strehl
et al., 2011). Additionally, starting with the second therapy
block (12th session) children are asked to practice their mental
strategies in specific situations at home or school for about
10 min each day. Together with the therapist children iden-
tify situations that require attention control (i.e., negativity
strategies: before starting to do homework; positivity strate-
gies: at night before going to bed). The children are asked
to document practicing by keeping a log which is controlled
by the therapist at the beginning of a session (see also Volle-
bregt et al. in this Frontiers Research Topic). If the child
practices each day between sessions he/she can earn an extra
token.
In the first and second therapy block the children complete
twelve NF sessions each. After those two blocks (with a 1 week
break to relieve families in between; see also Strehl et al., 2011)
a block reserved for the treatment of comorbid problems follows
(total of six sessions). In this block individual BT is applied for
the specific comorbid conditions. Treatment of those is based on
published intervention manuals. Then a final block with six NF
sessions follows that ends the therapy. In this block, the ratio of
negativity to positivity trials is set to 3:1.
Self-management
Before treatment all children receive standardized PE as described
in the NF section above. The SM training addresses children aged
6–12 years (Lauth and Schlottke, 2009), and is based on the self-
instruction training as described in Meichenbaum and Goodman
(1971). Goal of the training is to enhance child development in the
domains behavior regulation, planning, organization, and self-
reflection. A meta-analysis with k = 11 studies provides empirical
evidence of the training (Lauth and Schlottke, 2009; for the
general efficacy of such treatments see the reviews by Saile, 1996;
Fabiano et al., 2009). In the first therapy block the basic training
(12 sessions) is completed. This consists of the sessions (1) precise
looking; (2) precise describing; (3) precise listening; (4) precise
listening and re-telling; (5) precise account of perceptions; (6)
introduction of the stop-signal; (7) self-contained stopping and
checking; (8) accompanying checking procedures; (9) transfer
of checking techniques to school contexts; (10) self-instruction
with the stop signal; (11) self-instruction with difficult tasks; (12)
self-instruction under distraction. After 1 week break the second
therapy block follows with the strategy training: (1) basic skills;
(2) signal cards; (3) thinking loud; (4) flexible use of signal cards;
(5) adaptation of learned strategies for new tasks; (6) cross-linking
strategies; (7) discover systematic principles; (8) adaptation of
learned strategies for complex tasks; (9) solving abstract prob-
lems; (10) organizing learning strategies; (11) development of
strategies for complex school tasks; (12) application of strategies
for complex school tasks.
Each session (except the first one) begins with the recapitula-
tion of the last session and an introduction into the topic of the
session (10 min). This is followed by modeling the behavior that
the topic of the session requires (10 min) and the child trains this
for 20 min. The last 10 min are reserved for joint play to motivate
the child and to build a good therapeutic relationship. A token
plan is installed together with the child and the parents. As in
the NF group, the children can earn up to 5 tokens per session if
they stay attentive during the training unit. A full token plan of 15
tokens (every third session) can be exchanged into small rewards
by parents.
To keep both therapy groups balanced, quantity of homework
is kept identical. Starting in the second therapy block, the children
in the SM group are asked to practice self-instruction with the
stop signal during homework each day for 10 min. As in the NF
group, practicing is documented in a log which is controlled by
the therapist at the beginning of a session and the children can
also earn an extra token for doing the homework. Differing from
the NF protocol, the children do not practice relaxation, since this
is not part of the SM training.
Treatment of comorbid disorders
Depending on the comorbid disorder of the child, manualized
behavior treatments are applied. The most common comorbid
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disorder in our sample so far is Oppositional Defiant Disorder
(ODD). The principles to reduce such problem behaviors are
based on the training manuals used in the parent PE (see below).
In addition, after PE with the child token economies are also
introduced to reduce ODD symptoms. Other disorders such as
Tic Disorder, Enuresis, Sibling Rivalry Disorder are also treated
with BT, i.e., apart from token economies, habit reversal training,
alarm therapy, one to one quality time with the child (Esser,
2011). For children without comorbid disorders, those sessions
are used to resolve other conflicts that have an impairing quality,
i.e., children without many friends receive social competence
training.
Parent Training
Psycho-education only (PE). Since ADHD does not only affect
the child, but is specifically characterized by impairments at
home and school, the parent training supports the parents and
the transfer into the home setting. It is part of the training by
Lauth and Schlottke (2009). The core element is PE with respect
to ADHD, as well as development of strategies that effectively
support the child. Topics are: (1) information on ADHD; (2) han-
dling problem behavior I and introduction of token economies;
(3) joint parent-child play; (4) handling problem behavior II and
introduction of timeout and 1-2-3-Magic (Phelan, 2003); (5) han-
dling problem behavior in public. Between sessions, parents have
to complete homework, training the strategies in everyday life.
This homework is discussed in the following session. Therapists
are the same as in the children’s intervention. A meta-analysis
supports parent trainings as this one for ADHD (Bachmann et al.,
2008; Zwi et al., 2011). A total of five parent group sessions
lasting 100 min each are scheduled accompanying children’s
therapy.
PE + social support (SU). Parents in this group receive PE as
described above, with additional components on social support,
based on network oriented interventions (Röhrle et al., 1998),
since a study has shown positive effects of social support on
parental EEs, with parents with high social support showing more
positivity and warmth towards their children, that was related
to reduced comorbid oppositionality (Christiansen et al., 2010).
Parents are trained with network analyses to identify supporting
social networks, and to possibly activate them. If non-supportive
network characteristics are identified, modification is supported.
Between sessions, parents have to complete homework as in the
PE only group and additionally on individual social network
analyses. For this they have to think of ways of how to activate
positive social support. A total of five parent group sessions
lasting 100 min each are scheduled accompanying the children’s
therapy.
THERAPISTS
All therapists are trained in both NF, SM, PE, and PE+SU
and all therapists deliver all trainings based on interven-
tion manuals. All interventions for comorbid conditions are
also based on published intervention manuals. All thera-
pists are therapists in training and receive regular supervi-
sion (every fourth session) by a licensed supervisor with
more than 5 years experience in BT for the duration
of the trial. To control implementation and fidelity, all
sessions are videotaped and analyzed in the supervision
sessions.
MEASUREMENTS
With the exception of parent and teacher questionnaires, all
assessments are conducted in face-to-face contacts. Apart from
the primary ADHD outcomes (change in psychopathology from
baseline to post therapy) we are also interested in therapy related
quantitative EEG patterns of response to NF/SM. In the existing
NF studies, changes in EEG patterns have been reported after ther-
apy (e. g.: Monastra et al., 2005; Heinrich et al., 2007; Gevensleben
et al., 2009a; Arns et al., 2014; see also Garcia et al. in this
Frontiers Research Topic). But, differing from the homogeneous
results for parent and teacher ratings (primary outcomes), this
change proved to be heterogeneous according to meta-analysis
(Nestoriuc et al., 2011). Possible changes in EEG patterns before
and after therapy will thus be compared for both the NF and
SM group to establish whether changes are specific for the NF
group.
Selection and diagnostic measurements
1. Screening for the presence of ADHD symptoms is performed
with the Conners 3® parent and teacher ratings (German
version: Lidzba et al., 2013). Clinical impairment is established
with T-scores of ≥60.
2. The DSM-IV diagnosis of ADHD and possible comorbid
disorders is based on the semi-structured diagnostic inter-
view Kiddie-Sads-Present and Lifetime Version (K-SADS-PL:
Kaufman et al., 1996).
The 3rd edition of the CRS (Conners 3®: Conners, 2008; German
version: Lidzba et al., 2013) assess ADHD core symptoms as
well as Learning Problems, Executive Functioning, Peer- and
Family Relations, co-morbid conditions such as ODD and Con-
duct Disorder (CD) in children aged six (parent and teacher
forms) and eight (self-report forms) to 18 years of age. The
Conners 3® rating scales have been translated into German,
back-translated, and norms for a German-speaking sample were
established (Lidzba et al., 2013). A study on cultural compara-
bility of the German Conners 3® resulted in good model-fits for
confirmatory factor analyses (Christiansen et al., submitted), and
cultural comparability for a large group of Germans with Turkish
migration background could also be established (Schmidt et al.,
2013), with satisfactory internal consistencies of the scales in both
studies.
The K-SADS-PL (Kaufman et al., 1996; German adaptation
Delmo et al., 2011) is a semi-structured diagnostic interview
designed to assess current and past episodes of psychopathology
in children and adolescents according to DSM-III-R and DSM-
IV criteria. Probes and objective criteria are provided to rate
individual symptoms. The interview consists of two parts. The
first part is a screening interview that screens for the psychological
disorders. If an item is scored with “3” (0 = no information,
1 = nonexistent, 2 = below threshold, 3 = above threshold), the
full interview of this section is carried out. Diagnoses are then
based on DSM criteria that are listed and scored at the end of the
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full interview. The K-SADS has been carefully constructed and is
widely used.2
Outcome measures
Parent, and/or teacher ratings
1. The Conners 3® parent and teacher scales are used as the
measure of change of children’s ADHD symptoms (see above
Conners, 2008; German adaptation Lidzba et al., 2013). The
parent and teacher scales consist of 105 and 111 items respec-
tively that are rated on a four point Likert scale with sever-
ity ratings from 0 (not at all/never) to 3 (very much/very
frequently).
2. The Parental Stress Inventory (Eltern-Stress-Fragebogen
(ESF); Domsch and Lohaus, 2010) assesses with 38 items the
four subscales parenting stress, role restriction, social support,
and partnership. Internal consistency is satisfactory (0.76–
0.92) as well as re-test reliability (0.76–0.91). Convergent
validity has been established with the Parenting Stress Index.
3. The Parenting Scale (PS: Arnold et al., 1993; German version:
Miller, 2001) assesses parenting styles (reactions and strate-
gies) for different problematic situations. The two subscales
over-reacting and leniency have satisfactory internal consis-
tency (0.75), as well as the total scale (0.76).
4. Start, stop and dosis of stimulant medication are monitored
throughout the therapy. Since our clinic is a psychotherapeutic
department, medication treatment is monitored by children’s
pediatricians or child and adolescent psychiatrist. Parents
report what medication is given at what time and report on
titration procedures, as well as on side-effects.
Child ratings
5. The Qb-Test is a combined continuous performance (CPT)
and activity test for children aged 6–12 years (Ulberstad,
2012), which aims to objectively assess all three core symptoms
of ADHD in one test, and has been approved by the Food
and Drug Administration (FDA) in 2012. While performing
a standardized CPT on a computer, the movements of the
participant are recorded with an infrared camera following a
reflective marker attached to a headband that the participant
wears while performing the test. Factorial validity for the test
and the three core ADHD symptoms (inattention, hyperactiv-
ity, impulsivity) has been established (Reh et al., 2013), as well
as usefulness as a potential endophenotype assessment (Reh
et al., 2014).
6. The children’s test-battery of attention assessment (KITAP:
Zimmermann et al., 2002) assesses different attention param-
eters that are administered with a computer. Psychometric
properties of the KITAP have been reported in different studies
(Renner and Irblich, 2007; Kaufmann et al., 2010; Röthlis-
berger et al., 2010; Sobeh, 2010; Dreisörner and Georgiadis,
2011; Renner et al., 2012) as well as clinical validity for seven to
10 year old children with ADHD (Drechsler et al., 2009). In our
study the following subtests are included: sustained attention,
Go/No-Go, and divided attention.
2http://www.psychiatry.pitt.edu/research/tools-research/ksads-pl
7. The Child and Adolescent Social Support Scale (CASSS:
Malecki et al., 1999) is a 40-item multidimensional scale mea-
suring perceived social support from four sources: parents,
teachers, classmates, and friends. Frequency ratings consist
of a 6-point Likert Scale from 1 (Never) to 6 (Always).
Importance ratings consist of a 3-point Likert Scale rang-
ing from 1 (Not Important) to 3 (Very Important). Each
subscale corresponds to one of the sources of support (e.g.,
parent, teacher, classmate, and close friend) and consists of
10 items. Subscale scores are calculated by summing the fre-
quency ratings on the 10 items on each subscale. Analyses
revealed evidence of reliability, a four-factor structure (Parent,
Teacher, Classmate, and Close Friend subscales), and construct
validity. The CASSS co-varies with the clinically important
constructs of self-concept, social skills, and behavioral indica-
tors. There is evidence that the CASSS can be used to under-
stand children’s and adolescents’ perceived social support
(Malecki and Demaray, 2002).
8. The self-concept interview (Schöning et al., 2002) is a struc-
tured interview. Self-concept is assessed for school, family,
and peer-relations. The following categories are rated and
coping abilities are assessed: social interactions, perceived
quality of life and self-worth. Items are formulated in a
way that they do not confound with core ADHD symp-
toms. Internal consistency is satisfactory (range 0.70–0.83;
overall 0.85).
9. The KINDL-R (Ravens-Sieberer et al., 2003) assesses health
related quality of life of children and adolescents. Both parents
and children rate the six dimensions physical well-being, emo-
tional well-being, self-worth, family related well-being, peer
related well-being and school related well-being. A total of 24
items is to be rated on a 5-point Likert scale from 0 = never
to 4 = often. Internal consistency is satisfactory (0.85 for the
total scale, all subscales≥0.70), and the questionnaire has been
used in various studies with children (Ravens-Sieberer and
Bullinger, 1998a,b).
10. The Perceived Criticism Scale (PC) consists of the item “How
critical is your spouse of you” to be rated on 10-point Lik-
ert scale from 0 = not at all critical to 10 = very critical
indeed. Originally the item was used by Hooley (1990) to
assess high EE, i.e., hostility, criticism, and emotional over-
involvement, in spouses of patients with depression. With
40% variance explained, this item was the strongest predic-
tor of relapse in a 9 months follow-up. The item has been
translated into German and was adapted for children (How
much does your mum/dad like you?). This version has already
been successfully used with children with and without ADHD
(Christiansen et al., 2010).
11. Quantitative EEGs are assessed for both NF and SM groups
before therapy (T1), and post therapy (t3) as well as at six
(t4) and twelve (t5) months follow-up to establish whether NF
training results in changes specific for NF.
Primary and secondary outcome measures
The primary outcome measure is defined as the change of ADHD
hyperacitivity, inattention, and impulsivity symptoms according
to parent and teacher Conners 3® ratings (DSM-IV subscales
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and Conners’-ADHD-Index; Conners, 2008; German version:
Lidzba et al., 2013) at the end of the treatment (T3) compared
to T1. To establish stability of effects, T3 assessments will be
compared to six (T4) and 12 (T5) months follow-up assessments.
T2 assessment (after the first therapy block) will be used to estab-
lish effects compared to T1 without the treatment of comorbid
disorders.
Key secondary outcome measure is percentage of treatment
responders (defined as a reduction of at least 30% of
ADHD symptoms according to Conners-3 ratings of par-
ents and teachers) at the end of treatment and at follow-
ups. Qb-Test (Ulberstad, 2012; Reh et al., 2013), and KITAP
(Zimmermann et al., 2002) scores objectively assessing core
ADHD-symptoms and executive functions at follow-ups are fur-
ther key secondary outcome measures at the end of treatment
(T3).
Other secondary outcome measures are changes in quantita-
tive EEG patterns as well as changes in scores of self-concept, the
KINDL-R, PC, ESF, PS at the end of treatment and follow-ups.
STATISTICAL ANALYSES
Data will be analyzed according to the intent-to-treat (ITT)
principle, thus patients will be analyzed according to the random-
ization scheme. When appropriate (data missing completely at
random) the method “last observation carried forward” will be
applied. The treatment effects will be analyzed with multivariate
repeated measure ANOVAS with the within-subject factor “time”
(five levels: T1 to T5) and the between-subject factor “group” (NF
vs. SM; PE vs. PE+SU). Effect sizes will be reported with η2 =
0.039 defining a small, η2 = 0.110 a medium, and η2 = 0.200
a large effect. Gender and stimulant medications are important
control variables, as well as treatment response according to
primary outcomes. All analyses will be performed with SPSS 20
(SPSS Inc, Chicago, Il, USA).
Sample size
The primary outcome is the difference in the severity of ADHD
symptoms in the Conners 3© rating scales for parents and teach-
ers between the four treatment conditions (NF+PE vs. SM+PE
vs. NF+PE+SU vs. SM+PE+SU) at the end of treatment (T3) and
follow-up assessments (T4 and T5). ITT analyses as described will
be performed. Meta-analyses report medium to large effect-sizes
for behavioral ADHD interventions (Fabiano et al., 2009; Sonuga-
Barke et al., 2013) as well as for NF (Arns et al., 2009, 2014).
Sonuga-Barke et al. (2013, p. 1) state that when the best probably
blinded assessment is employed, effect sizes were substantially
attenuated to non-significant levels for all treatments except for
free fatty acid supplementation and artificial food color exclusion.
On the other hand, the meta-analyses by Fabiano et al. (2009)
and Arns et al. (2009) have demonstrated homogeneous and
robust effects for behavioral treatments and NF protocols, so
that we expect medium to large effect sizes for parent ratings
of ADHD and somewhat smaller effect sizes for teacher ratings.
Thus, with an assumed effect size of f = 0.25, a two-sided alpha
of 0.05, a power of 0.80, four groups (NF+ PE/NF+PE+SU;
SM+PE/SM+PE+SU) and five measurement time points, a total
of 97 children needs to be included (GPower© λ = 18.18, critical
F = 1.78, numerator df = 12.00, denominator df = 276, n = 97,
power = 0.80, Pillai V = 0.17). In order to adjust for loss of
power due to an anticipated dropout of 20%, 120 children will
be included in the study. Since the study is quite time con-
suming and the follow-up assessment fairly extensive, it seems
likely that not all families will follow through with the whole
study.
ETHICAL REVIEW AND TRIAL REGISTRATION
This RCT has been reviewed and approved by the local review
board of the Department of Psychology of the Philipps-University
Marburg (AZ: 2010-04). It is registered at www.clinicaltrials.gov
as NCT01879644.
PRELIMINARY RESULTS
From February 2011 till August 2014 a total of 74 children have
been screened for the study so far. Of those, 69 fulfilled study
entry criteria, but 11 dropped out of the study. Thus, a total of
58 children (83% boys) has completed the diagnostic study pro-
cedure (mean age 8.42 (SD 1.34), mean IQ 110 (SD 13.37); 23%
on medication; 48% with comorbid diagnoses such as ODD, Tic
Disorders, Enuresis, Sibling Rivalry Disorder, Separation Anxiety
Disorder). Of those, n = 32 children have already completed the
T3 and n = 17 the T4 assessments. Effects of parent training
groups cannot be reported here, since number of participants
of the four groups is overall too small for analyses (n < 10 per
group). Thus, preliminary data is only reported on the whole
sample and for a comparison of children in the NF vs. the SM
group.
An ANOVA on the whole sample with repeated measures
shows significant differences between T1 and T3 scores for the
Conners’ parent and teacher ratings: main effect time = F(1,35) =
17.31, p< 0.001, η2 = 0.331. For details for the different subscales,
please refer to Table 2A.
An ANOVA on the whole sample with repeated measures does
not show significant differences between T3 and T4 scores for the
Conners’ parent and teacher ratings: main effect time = F(6,11) =
0.59, p = 0.73, η2 = 0.244. For details for the different subscales,
please refer to Table 2B.
Comparing the NF and SM group in a preliminary ANOVA
with repeated measures, there is a multivariate significant main
effect time (F(2,27) = 6.98, p = 0.004, η2 = 0.34), but a multivariate
non-significant main effect group (F(2,27) = 0.43, p = 0.64, η2 =
0.03), and a multivariate non-significant interaction time∗group
(F(2,27) = 0.01, p = 0.81, η2 = 0.01) for the Conners ADHD-
index. Table 2C shows details of the two groups. The study
continues and future results with respect to the measures outlined
above and to group differences will be reported based on a larger
sample.
DISCUSSION
In this trial, information is collected on acceptance, feasibility,
and effectiveness of behavioral treatment with either NF or SM
in a high frequent outpatient setting, to establish whether NF is
a treatment alternative in such a setting. To collect such infor-
mation is important, since the majority of studies comparing
NF to other treatments are laboratory ones, making it difficult
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Table 2A | Conners-3 T1 and T3 scores for parent and teacher ratings: means and standard deviations (SD) for Conners-3 raw scores, F - and
p-values and η2.
Conners-3 T1 T3 F -Value p-Value η2
N = 32** N = 32**
ADHD index parent 11.75 (5.53) 7.13 (5.11) F(1,31) = 25.23 p < 0.001 η2p = 0.449
Inattention parent 29.56 (5.97) 15.16 (5.73) F(1,31) = 21.79 p < 0.001 η2p = 0.413
H/I* parent 18.78 (7.97) 14.00 (6.79) F(1,31) = 32.61 p < 0.001 η2p = 0.513
ADHD index teacher 10.59 (5.14) 7.09 (5.13) F(1,31) = 13.74 p = 0.001 η2p = 0.307
Inattention teacher 17.69 (4.84) 14.78 (5.58) F(1,31) = 8.54 p = 0.006 η2p = 0.216
H/I* teacher 16.03 (8.91) 12.69 (7.92) F(1,31) = 6.55 p = 0.016 η2p = 0.175
*H/I = Hyperactivity/Impulsivity.
**Both SM and NF together.
Table 2B | Conners-3 T3 and T4 scores for parent and teacher ratings: means and standard deviations (SD) for Conners-3 raw scores, F - and
p-values and η2.
Conners-3 T3 T4 F -Value p-Value η2
N = 17** N = 17**
ADHD index parent 7.53 (6.23) 7.41 (5.87) F(1,16) = 0.013 p = 0.91 η2p = 0.001
Inattention parent 15.41 (6.94) 14.88 (6.13) F(1,16) = 0.172 p = 0.68 η2p = 0.011
H/I* Parent 14.24 (7.79) 14.06 (8.03) F(1,16) = 0.26 p = 0.87 η2p = 0.002
ADHD index teacher 5.88 (5.52) 6.12 (5.48) F(1,16) = 0.039 p = 0.84 η2p = 0.002
Inattention teacher 13.76 (5.82) 13.41 (5.98) F(1,16) = 0.064 p = 0.80 η2p = 0.004
H/I* teacher 10.69 (6.32) 9.88 (8.08) F(1,16) = 0.264 p = 0.61 η2p = 0.016
*H/I = Hyperactivity/Impulsivity.
**Both SM and NF together.
Table 2C | Conners-3 T1 and T3 scores for parent and teacher ratings: means and standard deviations (SD) for Conners-3 raw scores for the SM
and NF group, F - and p-values and η2 for the main effects time and time*group.
Conners-3 Group T1 T3 F -Value p-Value η2
ADHD index parent SM 13.13 7.00
n = 15 (4.50) (4.45) Time*: F(1,27) = 23.11 p < 0.001 η2p = 0.461
NF 10.64 7.71 Time*Group*: F(1,27) = 2.89 p = 0.101 η2p = 0.097
n = 14 (6.35) (6.28)
ADHD index teacher SM 10.06 6.69
n = 15 (5.48) (5.37) Time*: F(1,27) = 12.99 p = 0.001 η2p = 0.325
NF 11.71 7.43 Time*Group*: F(1,27) = 0.273 p = 0.605 η2p = 0.010
n = 14 (4.71) (5.04)
*Univariate effects for the ADHD index for time and time*group for the SM and NF group.
to conclude whether such a treatment will be efficacious in a
naturalistic setting. Further, the majority of studies so far was
done with children either without comorbidities or stimulant
treatment (Arns et al., 2009; Fabiano et al., 2009), but this is not
the reality of families seeking help for their children with ADHD
(see introduction). So far we were able to include 58 children
and their parents in the study. About half the children present
with comorbid disorders and 23% are on medication. Reasons for
dropout of the study varied. For some families the setting was too
time consuming, other families came from far away and were able
to initialize support closer to home. The majority dropped out
of the study at the beginning of the treatment. Detailed results
on dropouts with respect to the NF and SM group, time points
and an extensive discussion of the reasons will follow when the
study is completed. So far, 32 children have completed the therapy,
and 17 have completed the follow-up (T4) assessment according
to the study protocol. Thus, our approach to recruit a natural
sample and to treat this in the described setting was feasible so
far.
First preliminary results of our study show positive train-
ing effects. Children in both groups (NF and SM) improve in
their psychopathology ratings according to parent and teacher
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Conners-3 scores over time. There is no significant difference
between groups (NF and SM) in changes over time. Since we
assumed that NF treatment will be at least equally effective,
this assumption is met. So far, those effects are stable over
time, since there is no significant change in Conners-3 scores
from post treatment (T3) to 6 months after treatment (T4).
Since this is an ongoing study we could only include 32 chil-
dren in our preliminary analysis. Thus, those results should
be perceived with caution. Results on primary and secondary
outcomes with respect to our research questions (i.e., group
differences, long-term effects, response rates, objective measures,
changes in medication etc.; see above) and for all four groups
(NF/SM, PE/PE+SU) will be presented when the full data set
is available. But, if this treatment in a time limited, high fre-
quent outpatient setting (three times a week over a period
of 12 weeks) continues to be as effective as our preliminary
results suggest, NF training might be an additional treatment
alternative for other outpatient clinics and private practices.
This would contribute to an improved patient centered care for
this large group of impaired children (Christiansen and Röhrle,
2012).
The greatest challenge of the study so far is the high frequency
of sessions. Today, the majority of children is involved in extracur-
ricular activities and/or parental duties make appointments
three times a week difficult. The total time frame (12 weeks)
somewhat eased reservations towards participation though, espe-
cially the fairly fast positive experiences related to the treat-
ment have proved to be very motivating for children and par-
ents. Considering the many studies that demonstrated shortend
delay reward gradients for children with ADHD, i.e., a prefer-
ence for smaller but sooner rewards (Sagvolden, 2000; Kuntsi
et al., 2001; Solanto et al., 2001; Sonuga-Barke, 2002, 2011;
Dalen et al., 2004; Antrop et al., 2006; Hoerger and Mace,
2006; Bitsakou et al., 2009; Tripp and Wickens, 2009), this
seems crucial for positive therapy effects, and indeed argues
for short and frequent therapy time frames, while coming
to the therapy sessions might not necessarily be perceived as
rewarding.
LIMITATIONS
A limitation of the study is the lack of blinding. Even though
randomization and stratification of study participants are
carefully done, treatment allocation is not blinded, as are of
course neither children, nor parents and therapists. To meet
this limitation, we decided to include likely objective outcome
measures as key secondary outcomes, i.e., the Qb-Test and the
KITAP. Both are computer based and assess the three ADHD core
symptoms (Qb-Test: Reh et al., 2013), and differential markers of
inattention (KITAP; Drechsler et al., 2009). Further, the probably
blinded assessment in the meta-analysis by Sonuga-Barke et al.
(2013) were teacher ADHD ratings and those are also part of the
primary outcome in our study. Those strategies, along with an
a priori power analysis and assessment of participants with and
without medication have been suggested to optimize designs in
NF research (Vollebregt et al., this Frontiers Research Topic).
All parents receive parent training. This in itself is an evidence
based intervention (Bachmann et al., 2008; Zwi et al., 2011),
and could cause confounder effects, especially since the PE part
includes strategies to manage problem behavior. But, children
aged seven to eleven rarely refer themselves to therapy (Kazdin,
2003), and psychotherapy effects for children are larger, when
parents are involved (Esser and Blank, 2011). Thus, not to include
parents would be against the state of the art, and would not
respect the needs of parents and caregivers.3 It might be difficult
to differentiate parent training effects for the two groups. But
since the PE part is identical in both groups, and the SU does
receive an addition on network-analyses, we do hope to be able
to discriminate effects for the two different conditions in this
study.
CONCLUSION
Despite these challenges and limitations, we think that this
study is a first step in establishing effective interventions in
primary psycho-therapeutic care for parents and children seeking
help for ADHD. According to our preliminary results, NF
and SM accompanied by parent training seem to be effective
in a high frequent outpatient setting. Since 23% of the chil-
dren are on medication, NF and SM training effects seem to
result in additional improvement. While the efficacy of psy-
chological treatments for children has frequently been shown,
the dissemination in routine care is still a problem to be
solved.
AUTHOR’S CONTRIBUTIONS
Hanna Christiansen designed the study and drafted the
manuscript. Verena Reh and Martin H. Schmidt conduct the
study and participated in the design of the study and performed
the power analysis. Winfried Rief conceived of the study, and
participated in its design and coordination and helped to draft the
manuscript. All authors read and approved the final manuscript.
AUTHOR’S INFORMATION
Hanna Christiansen, PhD, is a professor of clinical child and
adolescent psychology (chair) at the University of Marburg whose
main research interests are neuropsychology and treatment of
ADHD, children of mentally ill parents, and prevention of mental
disorders.
Verena Reh, PhD is a clinical psychologist whose main research
interests are behavioral assessment methods for ADHD, and
new psychological treatment options for childhood ADHD and
comorbid disorders.
Martin H. Schmidt is a psychologist (Dipl. -Psych.) and PhD
student whose main research interests are assessment methods for
ADHD in childhood and in adulthood, and new psychological
treatment methods for children, adolescents, and adults with
diagnosis of ADHD.
Winfried Rief, PhD, is a professor of clinical psychology and
psychotherapy (chair) at University of Marburg, head of the
outpatient clinic for psychological interventions, and head of the
postgraduate training program in cognitive-BT at University of
Marburg, Germany.
3http://www.nice.org.uk/guidance/cg72 (retrieved August 18th 2014).
Frontiers in Human Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 943 | 11
Christiansen et al. Neurofeedback in outpatient care
REFERENCES
Abikoff, H., Hechtman, L., Klein, R. G., Gallagher, R., Fleiss, K., Etcovitch, J. O. Y.,
et al. (2004a). Social functioning in children with ADHD treated with long-term
methylphenidate and multimodal psychosocial treatment. J. Am. Acad. Child
Adolesc. Psychiatry 43, 820–829. doi: 10.1097/01.chi.0000128797.91601.1a
Abikoff, H., Hechtman, L., Klein, R. G., Weiss, G., Fleiss, K., Etcovitch, J. O. Y., et al.
(2004b). Symptomatic improvement in children with ADHD treated with long-
term methylphenidate and multimodal psychosocial treatment. J. Am. Acad.
Child Adolesc. Psychiatry 43, 802–811. doi: 10.1097/01.chi.0000128791.10014.ac
Anney, R. J. L., Lasky-Su, J., Ó’Dúshláine, C., Kenny, E., Neale, B., Mulligan, A.,
et al. (2008). Conduct disorder and ADHD: evaluation of conduct problems
as a categorical and quantitative trait in the international multicentre ADHD
genetics study. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B, 1369–1378.
doi: 10.1002/ajmg.b.30871
Antrop, I., Stock, P., Verté, S., Wiersema, J. R., Baeyens, D., and Roeyers, H. (2006).
ADHD and delay aversion: the influence of non-temporal stimulation on choice
for delayed rewards. J. Child Psychol. Psychiatry 47, 1152–1158. doi: 10.1111/j.
1469-7610.2006.01619.x
Arnold, L. E., Lofthouse, N., Hersch, S., Pan, X., Hurt, E., Bates, B., et al. (2012).
EEG neurofeedback for ADHD double-blind sham-controlled randomized pilot
feasibility trial. J. Atten. Disord. 17, 410–419. doi: 10.1177/1087054712446173
Arnold, D. S., O’Leary, S. G., Wolff, L. S., and Acker, M. M. (1993). The parenting
scale: a measure of dysfunctional parenting in discipline situations. Psychol.
Assess. 5, 137–144. doi: 10.1037//1040-3590.5.2.137
Arns, M., de Ridder, S., Strehl, U., Breteler, M., and Coenen, A. (2009). Efficacy
of neurofeedback treatment in ADHD: the effects on inattention, impulsivity
and hyperactivity: a meta-analysis. Clin. EEG Neurosci. 40, 180–189. doi: 10.
1177/155005940904000311
Arns, M., Heinrich, H., and Strehl, U. (2014). Evaluation of neurofeedback in
ADHD: the long and winding road. Biol. Psychol. 95, 108–115. doi: 10.1016/j.
biopsycho.2013.11.013
Bachmann, M., Bachmann, C., Rief, W., and Mattejat, F. (2008). Efficacy of psy-
chiatric and psychotherapeutic interventions in children and adolescents with
psychiatric disorders—a systematic evaluation of meta-analyses and reviews:
part II: ADHD and conduct disorders. Z. Kinder Jugendpsychiatr. Psychother. 36,
321–333. doi: 10.1024/1422-4917.36.5.321
Barbaresi, W. J., Katusic, S. K., Colligan, R. C., Pankratz, V. S., Weaver, A. L., Weber,
K. J., et al. (2002). How common is attention-deficit/hyperactivity disorder?
Incidence in a population-based birth cohort in Rochester, Minn. Arch. Pediatr.
Adolesc. Med. 156, 217–224. doi: 10.1001/archpedi.156.3.217
Berger, I., Dor, T., Neo, Y., and Goldzweig, G. (2008). Attitudes toward
Attention-Deficit Hyperactivity Disorder (ADHD) treatment: parents‘ and chil-
dren’s perspecitives. J. Child Neurol. 23, 1036–1042. doi: 10.1177/0883073808
317726
Bitsakou, P., Psychogiou, L., Thompson, M., and Sonuga-Barke, E. J. S. (2009).
Delay aversion in attention deficit/hyperactivity disorder: an empirical investi-
gation of the broader phenotype. Neuropsychologia 47, 446–456. doi: 10.1016/j.
neuropsychologia.2008.09.015
Christiansen, H., Oades, R. D., Psychogiou, L., Hauffa, B. P., and Sonuga-
Barke, E. J. S. (2010). Does the cortisol response to stress mediate the
link between expressed emotion and oppositonal behavior in Attention-
Deficit/Hyperactivity-Disorder (ADHD)? Behav. Brain Funct. 6:45. doi: 10.
1186/1744-9081-6-45
Christiansen, H., and Röhrle, B. (2012). “Psychische störungen des kindes-
und jugendalters,” in Klinische Psychologie und Psychotherapie für Bachelor
Studierende, Bd. I, eds M. Berking and W. Rief (Berlin U. A.: Springer), 213–
234.
Conners, C. K. (2008). Conners 3rd Edition. Manual. North Tonawanda, NY: Multi-
Health Systems.
Dalen, L., Sonuga-Barke, E. J. S., Hall, M., and Remington, B. (2004). Inhibitory
deficits, delay aversion and preschool AD/HD: implications for the dual pathway
model. Neural Plast. 11, 1–11. doi: 10.1155/NP.2004.1
Dalsgaard, S., Nielsen, H. S., and Simonsen, M. (2013). Five-fold increase in
national prevalence rates of attention-deficit/hyperactivity disorder medications
for children and adolescents with autism spectrum disorder, attention-
deficit/hyperactivity disorder and other psychiatric disorders: a Danish
register-based study. J. Child Adolesc. Psychopharmacol. 23, 432–439. doi: 10.
1089/cap.2012.0111
DeBeus, R. (2006). “Progress in efficacy studies of EEG biofeedback for ADHD,”
in Paper Presented at the Annual Meeting of the American Psychiatric Association
(Toronto, Canada).
DeBeus, R. J., and Kaiser, D. A. (2011). Neurofeedback with children with
attention deficit hyperactivity disorder: a randomized doubleblind placebo-
controlled study. Neurofeedback Neuromodulation Tech. Appl. 16, 127–152.
doi: 10.1016/B978-0-12-382235-2.00005-6
Delmo, C., Weiffenbach, O., Gabriel, M., Stadler, C., and Poustka, F. (2011).
Diagnostisches Interview Kiddie-Sads-Present and Lifetime Version (K-SADS-PL).
5. Auflage der deutschen Forschungsversion, erweitert um ICD-10-Diagnostik.
Frankfurt: Klinik für Psychiatrie und Psychotherapie des Kindes-und Jugendal-
ters, 1–241.
Domsch, H., and Lohaus, A. (2010). Elternstressfragebogen (ESF). Göttingen und
Bern: Hogrefe.
Drabick, D. A. G., Gadow, K. D., and Sprafkin, J. (2006). Co-occurrence of
conduct disorder and depression in a clinic-based sample of boys with
ADHD. J. Child Psychol. Psychiatry 47, 766–774. doi: 10.1111/j.1469-7610.2006.
01625.x
Drechsler, R., Rizzo, P., and Steinhausen, H.-C. (2009). Zur klinischen Validität
einer computergestützten Aufmerksamkeitsbatterie für Kinder (KITAP) bei 7–
10-jährigen Kindern mit ADHS: the clinical validity of a computerized test
battery for attentional performance for children. Child. Dev. 18, 153–161.
doi: 10.1026/0942-5403.18.3.153
Drechsler, R., Straub, M., Doehnert, M., Heinrich, H., Steinhausen, H.-C.,
and Brandeis, D. (2007). Controlled evaluation of a neurofeedback training
of slow cortical potentials in children with Attention Deficit/Hyperactivity
Disorder (ADHD). Behav. Brain Funct. 3:35. doi: 10.1186/1744-9081-
3-35
Dreisörner, T., and Georgiadis, J. (2011). Sensitivität und Spezifität
computergestützter Verfahren zur Diagnostik von Aufmerksamkeitsdefizit-
/Hyperaktivitätsstörung (ADHS) im Kindes-und Jugendalter-Die Testbatterie
zur Aufmerksamkeitsprüfung (TAP). Empir. Spec. Educ. 1, 3–19.
Du Paul, G. J., Barkley, R. A., and Connor, D. F. (1998). “Stimulants,” in Attention
Deficit Hyperactivity Disorder: A Handbbok for Diagnosis and Treatment, ed R. A.
Barkely (New York: Guilford Press), 510–551.
Esser, G. (2011). Lehrbuch der Klinischen Psychologie u. Psychotherapie bei Kindern
+ Jugendlichen. Stuttgart and New York: Thieme.
Esser, G., and Blank, S. (2011). Efficacy of psychotherapy with children and
adolescents. Prax. Kinderpsychol. Kinderpsychiatr. 60, 626–638.
Fabiano, G. A., Pelham, W. E. Jr., Coles, E. K., Gnagy, E. M., Chronis-Tuscano,
A., and O’Connor, B. C. (2009). A meta-analysis of behavioral treatments for
attentiondeficit/hyperactivity disorder. Clin. Psychol. Rev. 29, 129–140. doi: 10.
1016/j.cpr.2008.11.001
Gadow, K. D., DeVincent, C. J., and Pomeroy, J. (2006). ADHD symptom subtypes
in children with pervaisive developmental disorder. J. Autism Dev. Disord. 36,
271–283. doi: 10.1007/s10803-005-0060-3
Gevensleben, H., Holl, B., Albrecht, B., Schlamp, D., Kratz, O., Studer, P., et al.
(2009a). Distinct EEG effects related to neurofeedback training in children with
ADHD: a randomized controlled trial. Int. J. Psychophysiol. 74, 149–157. doi: 10.
1016/j.ijpsycho.2009.08.005
Gevensleben, H., Holl, B., Albrecht, B., Schlamp, D., Kratz, O., Studer, P., et al.
(2010). Neurofeedback training in children with ADHD: 6-month follow-up of
a randomized controlled trial. Eur. Child Adolesc. Psychiatry 19, 715–724. doi: 10.
1007/s00787-010-0109-5
Gevensleben, H., Holl, B., Albrecht, B., Vogel, C., Schlamp, D., Kratz, O., et al.
(2009b). Is neurofeedback an efficacious treatment for ADHD? A randomised
controlled clinical trial. J. Child Psychol. Psychiatry 50, 780–789. doi: 10.1111/j.
1469-7610.2008.02033.x
Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann,
R. W., et al. (2011). European guidelines on managing adverse effects of
medication for ADHD. Eur. Child Adolesc. Psychiatry 20, 17–37. doi: 10.
1007/s00787-010-0140-6
Greenhill, L. L., Halperin, J. M., and Abikoff, H. (1999). Stimulant medications.
J. Am. Acad. Child Adolesc. Psychiatry 38, 503–512. doi: 10.1097/00004583-
199905000-00011
Heinrich, H., Gevensleben, H., and Strehl, U. (2007). Annotation: neurofeedback—
train your brain to train behavior. J. Child Psychol. Psychiatry 48, 3–16. doi: 10.
1111/j.1469-7610.2006.01665.x
Frontiers in Human Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 943 | 12
Christiansen et al. Neurofeedback in outpatient care
Hodgson, K., Hutchinson, A. D., and Denson, L. (2014). Nonpharmacological
treatments for ADHD: a meta-analytic review. J. Atten. Disord. 18, 275–282.
doi: 10.1177/1087054712444732
Hoerger, M. L., and Mace, F. C. (2006). A computerized test of self-control predicts
classroom behavior. J. Appl. Behav. Anal. 39, 147–159. doi: 10.1901/jaba.2006.
171-04
Hooley, J. M. (1990). “Expressed emotion and depression,” in Depression and
Families: Impact and Treatment, ed G. I. Keitner (Washington, DC: American
Psychiatry Press), 57–83.
Jakobson, A., and Kikas, E. (2007). Cognitive functioning in children with
and without attention-deficit/hyperactivity disorder with and without
comorbid learning disabilities. J. Learn. Disabil. 40, 194–202. doi: 10.
1177/00222194070400030101
Jensen, P. S., Arnold, L. E., Swanson, J. M., Vitiello, B., Abikoff, H. B., Greenhill,
L. L., et al. (2007). 3-year follow-up of the NIMH MTA study. J. Am. Acad. Child
Adolesc. Psychiatry 46, 989–1002. doi: 10.1097/CHI.0b013e3180686d48
Kadesjö, C., Hagglof, B., Kadesjö, B., and Gillberg, C. (2003). Attention-
Deficit/Hyperactivity Disorder: review and recommendations for future
research. Clin. Child Fam. Psychol. Rev. 4, 183–207.
Kaufman, J., Birmaher, B., Brent, D., Rao, U., and Ryan, N. (1996).
Kiddie-Sads-Present and Lifetime Version (K-SADS-PL). Pittsburgh,
University of Pittsburgh, School of Medicine. Available online at:
http://www.psychiatry.pitt.edu/sites/default/files/Documents/assessments/ksads-
pl.pdf.
Kaufmann, L., Zieren, N., Zotter, S., Karall, D., Scholl-Bürgi, S., Haber-
landt, E., et al. (2010). Predictive validity of attentional functions in dif-
ferentiating children with and without ADHD: a componential analy-
sis. Dev. Med. Child Neurol. 52, 371–378. doi: 10.1111/j.1469-8749.2009.
03560.x
Kazdin, A. E. (2003). Psychotherapy for children and adolescents. Annu.
Rev. Psychol. 54, 253–276. doi: 10.1146/annurev.psych.54.101601.14
5105
Kuntsi, J., Oosterlaan, J., and Stevenson, J. (2001). Psychological mechanisms in
hyperactivity: I response inhibition deficit, working memory impairment, delay
aversion, or something else?. J. Child Psychol. Psychiatry 42, 199–210. doi: 10.
1111/1469-7610.00711
Lansbergen, M. M., van Dongen-Boomsma, M., Buitelaar, J. K., and Slaats-
Willemse, D. (2011). ADHD and EEG-neurofeedback: a double-blind random-
ized placebo-controlled feasibility study. J. Neural Transm. 118, 275–284. doi: 10.
1007/s00702-010-0524-2
Lauth, G. W., and Schlottke, P. F. (2009). Training Mit Aufmerksamkeitsgestörten
Kindern. 6th Edn. Weinheim, Basel: Beltz PVU.
Leins, U. H. T., Kaller, S., Schober, F., Weber, C., and Strehl, U. (2006). Neurofeed-
back for children with ADHD: a comparison of SCP- and theta/beta-protocols.
Prax. Kinderpsychol. Kinderpsychiatr. 55, 384–407.
Lidzba, K., Christiansen, H., and Drechsler, R. (2013). Conners-3D: Deutsche
Adaptation der Conners 3rd Edition™ (Conners 3) TM . Göttingen und Bern:
Hogrefe.
Liew, A. (2014). EEG biofeedback therapy for ADHD: a systematic review. J. Neurol.
Neurosurg. Psychiatry 85:e3. doi: 10.1136/jnnp-2014-308883.34
Lofthouse, N., Arnold, L. E., and Hurt, E. (2012). Current status of neurofeedback
for Attention-Deficit/Hyperactivity Disorder. Curr. Psychiatry Rep. 14, 536–542.
doi: 10.1007/s11920-012-0301-z
Logemann, H. N., Lansbergen, M. M., Van Os, T. W., Böcker, K. B., and Kenemans,
J. L. (2010). The effectiveness of EEG-feedback on attention, impulsivity and
EEG: a sham feedback controlled study. Neurosci. Lett. 479, 49–53. doi: 10.
1016/j.neulet.2010.05.026
Malecki, K. C., and Demaray, M. (2002). Measuring perceived social support:
development of the child and adolescent social support scale (CASSS). Psychol.
Sch. 39, 1–18. doi: 10.1002/pits.10004
Malecki, C. K., Demaray, M. K., Elliott, S. N., and Nolten, P. W. (1999).
The Child and Adolescent Social Support Scale. DeKalb, IL: Northern Illinois
University.
Meichenbaum, D. H., and Goodman, J. (1971). Training impulsive children to talk
to themselves: a means of developing self-control. J. Abnorm. Psychol. 77, 115–
126. doi: 10.1037/h0030773
Miller, Y. (2001). Erziehung von Kindern im Kindergartenalter: Erziehungsver-
halten und Kompetenzüberzeugungen von Eltern und der Zusammenhang
zu kindlichen Verhaltensstörungen. University of Braunschweig: Inaugural
Dissertation.
Molina, B. S., Hinshaw, S. P., Eugene Arnold, L., Swanson, J. M., Pelham, W. E.,
Hechtman, L., et al. (2013). Adolescent substance use in the multimodal
treatment study of Attention-Deficit/Hyperactivity Disorder (ADHD)(MTA) as
a function of childhood ADHD, random assignment to childhood treatments
and subsequent medication. J. Am. Acad. Child Adolesc. Psychiatry 52, 250–263.
doi: 10.1016/j.jaac.2012.12.014
Molina, B. S. G., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen,
P. S., et al. (2009). The MTA at 8 Years: prospective follow-up of children treated
for combined-type ADHD in a Multisite study. J. Am. Acad. Child Adolesc.
Psychiatry 48, 484–500. doi: 10.1097/CHI.0b013e31819c23d0
Monastra, V. J., Lynn, S., Linden, M., Lubar, J. F., Gruzelier, J., and LaVaque, T. J.
(2005). Electroencephalographic biofeedback in the treatment of Attention-
Deficit/Hyperactivity Disorder. Appl. Psychophysiol. Biofeedback 30, 95–114.
doi: 10.1007/s10484-005-4305-x
Moriyama, T. S., Polanczyk, G., Caye, A., Banaschweski, T., Brandeis, D., and Rohde,
L. A. (2012). Evidence-based information on the clinical use of neurofeedback
for ADHD. Neurotherapeutics 9, 588–598. doi: 10.1007/s13311-012-
0136-7
Mrug, S., Molina, B. S., Hoza, B., Gerdes, A. C., Hinshaw, S. P., Hechtman, L.,
et al. (2012). Peer rejection and friendships in children with Attention-
Deficit/Hyperactivity Disorder: contributions to long-term outcomes.
J. Abnorm. Child Psychol. 40, 1013–1026. doi: 10.1007/s10802-012-
9610-2
MTA Cooperative Group (1999). A 14-month randomized clinical trial
of treatment strategies for Attention-Deficit/Hyperactivity Disorder. The
MTA Cooperative Group. Multimodal treatment study of children with
ADHD. Arch. Gen. Psychiatry 12, 1073–1086. doi: 10.1001/archpsyc.56.12.
1073
Nestoriuc, Y., Christiansen, H., Martin, A., and Rief, W. (2011). Efficacy of neu-
rofeedback treatment studies in ADHD: a meta-analysis. Poster Presentation at
the 2011 Budapest Meeting of the European Network on Hyperkinetic Disorders
(Eunethydis) (Budapest, Hungary).
Nieweg, E. H. (2010). Does ADHD medication stop working after 2-3 years? On the
surprising but little-known follow-up of the MTA study. Tijdschr. Psychiatr. 52,
245–254.
Perreau-Linck, E., Lessard, N., Lévesque, J., and Beauregard, M. (2010). Effects of
neurofeedback training on inhibitory capacities in ADHD children: a single-
blind, randomized, placebo-controlled study. J. Neurother. 14, 229–242. doi: 10.
1080/10874208.2010.501514
Phelan, T. W. (2003). 1–2-3 Magic Effective Discipline for Children 2–12. Glen Ellyn,
Illinois: ParentMagic, Inc.
Picard, C., Moreau, G., Guay, M. C., and Achim, A. (2006). “Double double-blind
sham study of neurofeedback treatment in children with ADHD,” in Proceedings
of the Meeting of the International Society for Neurofeedback and Research: 2006
(Atlanta, GA).
Ravens-Sieberer, U., Bettge, S., and Erhart, M. (2003). Lebensqualität von
kindern und jugendlichen. Ergebnisse aus der pilotphase des kinder- und
jugendgesundheitssuveys. Bundesgesundheitsblatt Gesundheitsforschung Gesund-
heitsschutz 46, 340–345. doi: 10.1007/s00103-002-0562-5. [Epub ahead of
print].
Ravens-Sieberer, U., and Bullinger, M. (1998a). Assessing health-related quality
of life in chronically ill children with the German KINDL: first psychometric
and content analytical results. Qual. Life Res. 7, 399–407. doi: 10.
1023/a:1008853819715
Ravens-Sieberer, U., and Bullinger, M. (1998b). News from the KINDL-
Questionnaire—A new version for adolescents. Qual. Life Res. 7, 653.
Reh, V., Schmidt, M. H., Lam, L., Schimmelmann, B. B., Hebebrand, J., Rief,
W., et al. (2013). Behavioral assessment of core ADHD symptoms using the
QbTest. J. Atten. Disord. doi: 10.1177/1087054712472981. [Epub ahead of
print].
Reh, V., Schmidt, M., Rief, W., and Christiansen, H. (2014). Preliminary evidence
for altered motion tracking-based hyperactivity in ADHD siblings. Behav. Brain
Funct. 10:7. doi: 10.1186/1744-9081-10-7
Renner, G., and Irblich, D. (2007). Testbatterie zur Aufmerksamkeitsprüfung für
Kinder (KITAP). Z. Entwicklungspsychol. Padagog. Psychol. 39, 206–214. doi: 10.
1026/0049-8637.39.4.206
Frontiers in Human Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 943 | 13
Christiansen et al. Neurofeedback in outpatient care
Renner, G., Lessing, T., Krampen, G., and Irblich, D. (2012). Reliabilität und Retest-
Stabilität der “Testbatterie zur Aufmerksamkeitsprüfung für Kinder” (KITAP)
bei 6-bis 7-jährigen Kindern. Z. Neuropsychol. 23, 27–36. doi: 10.1024/1016-
264x/a000059
Röhrle, B., Sommer, G., and Nestmann, F. (1998). Netzwerkintervention. Fortschritte
der Gemeindepsychologie und Gesundheitsförderung. (Vol. 2), Tübingen: dgvt
Verlag.
Röthlisberger, M., Neuenschwander, R., Michel, E., and Roebers,
C. M. (2010). Exekutive Funktionen: Zugrundeliegende kognitive
Prozesse und deren Korrelate bei Kindern im späten Vorschulalter. Z.
Entwicklungspsychol. Padagog. Psychol. 42, 99–110. doi: 10.1026/0049-8637/a00
0010
Sagvolden, T. (2000). Behavioral validation of the spontaneously hyperten-
sive rat (SHR) as an animal model of Attention-Deficit/Hyperactivity Dis-
order (AD/HD). Neurosci. Biobehav. Rev. 24, 31–39. doi: 10.1016/s0149-
7634(99)00058-5
Saile, H. (1996). Metaanalyse zur effektivität psychologischer behandlung hyperak-
tiver kinder. Z. Klin. Psychol. 25, 190–207.
Sattler, J. M. (2008). Assessment of Children. San Diego: Jerome M. Sattler, Publish-
ing, Inc.
Schachar, R., Taylor, E., Wieselberg, M., Thorley, G., and Rutter, M. (1987).
Changes in family function and relationships in children who respond to
Methylphenidate. J. Am. Acad. Child Adolesc. Psychiatry 26, 728–732. doi: 10.
1097/00004583-198709000-00019
Schachter, H. M., Pham, B., King, J., Langford, S., and Moher, D. (2001). How effi-
cacious and safe is short-acting methylphenidate for the treatment of Attention-
Deficit Disorder in children and adolescents? A meta-analysis. CMAJ 165, 1475–
1488.
Schlegelmilch, F., Markert, S., Berkes, S., and Schellhorn, K. (2004). Online ocular
artifact removal for dc-EEG-signals: estimation of dc-level. Biomed. Tech. 49,
340–341.
Schmidt, M., Reh, V., Hirsch, O., Rief, W., and Christiansen, H. (2013). Assess-
ment of ADHD symptoms and the issue of cultural variation. Are conners
3rd rating scales applicable to children and parents with migration back-
ground?. J. Atten. Disord. doi: 10.1177/1087054713493319. [Epub ahead of
print].
Schöning, S., Steins, G., and Berek, M. (2002). Das Selbstkonzept von Kindern mit
Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHD) und dessen Verän-
derung mit Methylphenidat. Kindheit Entwicklung 11, 38–47. doi: 10.
1026//0942-5403.11.1.38
Semrud-Clikeman, M., and Bledsoe, J. (2011). Updates on Attention-
Deficit/Hyperactivity Disorder and learning disorders. Curr. Psychiatry
Rep. 13, 364–373. doi: 10.1007/s11920-011-0211-5
Sobeh, J. (2010). Aufmerksamkeitsfunktionen und Ihre Entwicklung bei Vor- und
Grundschulkindern. Göttingen: Cuvillier-Verlag.
Solanto, M. V., Abikoff, H., Sonuga-Barke, E., Schachar, R., Logan, G. D., Wigal, T.,
et al. (2001). The ecological validity of delay aversion and response inhibition
as measures of impulsivity in AD/HD: a supplement to the NIMH multimodal
treatment study of AD/HD. J. Abnorm. Child Psychol. 29, 215–228. doi: 10.
1023/A:1010329714819
Sonuga-Barke, E. J. S. (2002). Psychological heterogeneity in AD/HD—a dual
pathway model of behaviour and cognition. Behav. Brain Res. 130, 29–36.
doi: 10.1016/S0166-4328(01)00432-6
Sonuga-Barke, E. J. S. (2011). Editorial: ADHD as a reinforcement disorder-
moving from general effects to identifying (six) specific models to test.
J. Child Psychol. Psychiatry 52, 917–918. doi: 10.1111/j.1469-7610.2011.
02444.x
Sonuga-Barke, E. J. S., Brandeis, D., Cortese, S., Daley, D., Ferrin, M., Holtmann,
M., et al. (2013). Nonpharmacological interventions for adhd: systematic review
and meta-analyses of randomized controlled trials of dietary and psycholog-
ical treatments. Am. J. Psychiatry 170, 275–289. doi: 10.1176/appi.ajp.2012.
12070991
Stein, D. S., Blum, N. J., and Barbaresi, W. J. (2011). Developmental and behavioral
disorders through the life-span. Pediatrics 128, 364–373. doi: 10.1542/peds.
2011-0266
Steinhausen, H. C., and Bisgaard, C. (2014). Nationwide time trends in dis-
pensed prescriptions of psychotropic medication for children and adolescents
in Denmark. Acta Psychiatr. Scand. 129, 221–231. doi: 10.1111/acps.
12155
Strehl, U. (2009). Slow cortical potentials neurofeedback. J. Neurother. 13, 117–126.
doi: 10.1080/10874200902885936
Strehl, U., Goth, G., Klinger, C., Hinterberger, T., and Birbaumer, N. (2006).
Self-regulation of slow cortical potentials: a new treatment for children with
Attention-Deficit/Hyperactivity Disorder. Pediatrics 118, e1530–e1540. doi: 10.
1542/peds.2005-2478
Strehl, U., Leins, U., and Heinrich, H. (2011). “Aufmerksamkeitsdefizit-
/Hyperaktivitätsstörung (ADHS),” in BiofeedbacK Grundlagen, Indikationen,
Kommunikation, Vorgehen, eds W. Rief and N. Birbaumer (Stuttgart: Schat-
tauer), 238–426.
Swanson, J., Arnold, L. E., Kraemer, H., Hechtman, L., Molina, B., Hinshaw, S.,
et al. (2008). Evidence, interpretation and qualification from multiple reports
of long-term outcomes in the Multimodal Treatment Study of children with
ADHD (MTA). J. Atten. Disord. 12, 15–43. doi: 10.1177/1087054708319525
Swanson, J. M., Kraemer, H. C., Hinshaw, S. P., Arnold, L. E., Conners, C. K.,
Abikoff, H. B., et al. (2001). Clinical relevance of the primary findings of the
MTA: success rates based on severity of ADHD and ODD symptoms at the
end of treatment. J. Am. Acad. Child Adolesc. Psychiatry 40, 168–179. doi: 10.
1097/00004583-200102000-00011
Taylor, E., Chadwick, O., Heptinstall, E., and Danckaerts, M. (1996). Hyperactivity
and conduct problems as risk factors for adolescence development. J. Am. Acad.
Child Adolesc. Psychiatry 35, 1213–1226. doi: 10.1097/00004583-199609000-
00019
Taylor, E. A., Sandberg, S., Thorley, G., and Giles, S. (1991). The Epidemiology of
Childhood Hyperactivity. Oxford: Oxford University Press.
Tripp, G., and Wickens, J. R. (2009). Neurobiology of ADHD. Neuropharmacology
57, 579–589. doi: 10.1016/j.neuropharm.2009.07.026
Tully, L. A., Arseneault, L., Caspi, A., Moffitt, T. E., and Morgan, J.
(2004). Does maternal warmth moderate the effects of birth weight on
twins’ Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms and low
IQ?. J. Consult. Clin. Psychol. 72, 218–226. doi: 10.1037/0022-006X.72.
2.218
Ulberstad, F. (2012). QbTest Technical Manual (rev. eD). Stockholm, Sweden:
Qbtech AB.
U.S. Department of Health and Human Services. Mental Health. (1999). A Report
of the Surgeon General. Rockville, MD: U.S. Department of Health and Human
Services, Substance Abuse and Mental Health Services Adminstration, Center
for Mental Health Services, Nation Institutes of Health, National Institute of
Mental Health.
Vakil, E., Blachstein, H., Wertman-Elad, R., and Greenstein, Y. (2012). Verbal
learning and memory as measured by the rey-auditory verbal learning test:
ADHD with and without learning disabilities. Child Neuropsychol. 18, 449–466.
doi: 10.1080/09297049.2011.613816
van de Loo-Neus, G. H. H., Rommelse, N., and Buitelaar, J. K. (2011). To stop
or not to stop? How long should medication treatment of Attention-Deficit
Hyperactivity Disorder be extended?. Eur. Neuropsychopharmacol. 21, 584–599.
doi: 10.1016/j.euroneuro.2011.03.008
Van der Oord, S., Prins, P. J., Oosterlaan, J., and Emmelkamp, P. M. (2008). Efficacy
of methylphenidate, psychosocial treatments and their combination in school-
aged children with ADHD: a metaanalysis. Clin. Psychol. Rev. 28, 783–800.
doi: 10.1016/j.cpr.2007.10.007
Visser, S. N., and Lesesne, C. A. (2003). Mental health in the United States:
prevalence of diagnosis and medication treatment for Attention-Deficit Hyper-
activity Disorder: United States. MMWR Morb. Mortal. Wkly. Rep. 54,
842–847.
Whalen, C. K., and Henker, B. (1991). Therapies for hyperactive children: com-
parisons, combinations and compromises. J. Consult. Clin. Psychol. 59, 126–137.
doi: 10.1037/0022-006X.59.1.126
Willcutt, E. G., Pennington, B. F., Oson, R. K., Chhabildas, N., and Huslander, J.
(2005). Neuropsychological analyses of comorbidity between reading disability
and attention deficit hyperactivity disorder: in search of the common deficit.
Dev. Neuropsychol. 27, 35–78. doi: 10.1207/s15326942dn2701_3
Zimmermann, P., Gondan, M., and Fimm, B. (2002). KITAP Testbatterie
zur Aufmerksamkeitsprüfung Für Kinder. Herzogenrath: Psychologische
Testsysteme.
Frontiers in Human Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 943 | 14
Christiansen et al. Neurofeedback in outpatient care
Zwi, M., Jones, H., Thorgaard, C., York, A., and Dennis, J. A. (2011). Parent
training interventions for Attention Deficit Hyperactivity Disorder (ADHD)
in children aged 5 to 18 years. Cochrane Database Syst. Rev. 2011:CD003018.
doi: 10.1002/14651858.CD003018.pub3
Conflict of Interest Statement: The authors declare that the research was conducted
in the absence of any commercial or financial relationships that could be construed
as a potential conflict of interest.
Received: 19 August 2014; accepted: 05 November 2014; published online: 26 November
2014.
Citation: Christiansen H, Reh V, Schmidt MH and Rief W (2014) Slow cortical
potential neurofeedback and self-management training in outpatient care for children
with ADHD: study protocol and first preliminary results of a randomized controlled
trial. Front. Hum. Neurosci. 8:943. doi: 10.3389/fnhum.2014.00943
This article was submitted to the journal Frontiers in Human Neuroscience.
Copyright © 2014 Christiansen, Reh, Schmidt and Rief. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution and reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Human Neuroscience www.frontiersin.org November 2014 | Volume 8 | Article 943 | 15
